4771 Stock Overview
Engages in the manufacturing of medical equipment in Taiwan, China, Japan, and the United States.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 5/6 |
Dividends | 1/6 |
Vizionfocus Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$296.00 |
52 Week High | NT$384.50 |
52 Week Low | NT$187.50 |
Beta | 1.17 |
1 Month Change | -5.58% |
3 Month Change | -7.93% |
1 Year Change | 54.97% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 101.36% |
Recent News & Updates
Shareholder Returns
4771 | TW Medical Equipment | TW Market | |
---|---|---|---|
7D | 1.5% | 2.8% | -2.1% |
1Y | 55.0% | 9.0% | 26.1% |
Return vs Industry: 4771 exceeded the TW Medical Equipment industry which returned 7% over the past year.
Return vs Market: 4771 exceeded the TW Market which returned 27.4% over the past year.
Price Volatility
4771 volatility | |
---|---|
4771 Average Weekly Movement | 6.2% |
Medical Equipment Industry Average Movement | 3.9% |
Market Average Movement | 4.8% |
10% most volatile stocks in TW Market | 8.6% |
10% least volatile stocks in TW Market | 2.3% |
Stable Share Price: 4771's share price has been volatile over the past 3 months.
Volatility Over Time: 4771's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | n/a | An Shi | www.vizionfocus.com |
Vizionfocus Inc. engages in the manufacturing of medical equipment in Taiwan, China, Japan, and the United States. It also manufactures mechanical equipment, optical instruments, and precision instruments; trades internationally; and provides other consulting services. In addition, the company engages in the research and development, design, development, production, and wholesale of contact lenses.
Vizionfocus Inc. Fundamentals Summary
4771 fundamental statistics | |
---|---|
Market cap | NT$15.53b |
Earnings (TTM) | NT$654.83m |
Revenue (TTM) | NT$2.83b |
23.7x
P/E Ratio5.5x
P/S RatioIs 4771 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4771 income statement (TTM) | |
---|---|
Revenue | NT$2.83b |
Cost of Revenue | NT$1.67b |
Gross Profit | NT$1.16b |
Other Expenses | NT$504.38m |
Earnings | NT$654.83m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 12.48 |
Gross Margin | 40.94% |
Net Profit Margin | 23.13% |
Debt/Equity Ratio | 32.8% |
How did 4771 perform over the long term?
See historical performance and comparison